首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1637687

2031 年亚太地区放射肿瘤学市场预测 - 区域分析 - 按类型和应用

Asia Pacific Radiation Oncology Market Forecast to 2031 - Regional Analysis - by Types and Application

出版日期: 2024年11月22日 | 出版商:

The Insight Partners | 英文 89 Pages | 订单完成后即时交付

价格

简介目录图表

2023年亚太地区放射肿瘤市值为11.0574亿美元，预计2031年将达到34.1789亿美元；预计2023年至2031年复合年增长率为15.1%。

放射肿瘤学策略措施推动亚太放射肿瘤学市场

放射肿瘤学在癌症治疗方面具有巨大的潜力。此外，市场参与者在产品开发、创新、产品发布、产品批准、合併、收购和合作伙伴关係等方面不断发展放射治疗预计将有助于市场成长。市场上最近采取的一些策略性倡议是

2024 年 5 月，Elekta 推出了最新的直线加速器 (linac) Evo，这是一款具有新型高清 AI 增强成像的 CT-Linac，能够提供离线和线上自适应放射治疗以及改进的标准影像引导放射治疗。
2024 年 5 月，The Icon Group 与 Cyberknife Australia Pty Ltd 合作建立多达 6 家新的放射肿瘤诊所（拟成立合资企业），将使用「Cyberknife」系统提供放射肿瘤治疗。
2024 年5 月，GE HealthCare 推出了Revolution RT，这是一种新型放射治疗电脑断层扫描(CT) 解决方案，具有创新的硬体和软体解决方案，有助于提高成像准确性，同时简化模拟工作流程，为临床医生和患者提供更个人化和无缝的肿瘤护理路径体验。
2024 年4 月，Accuray Incorporated 在ESTRO 2024 上展示了旨在改善癌症治疗体验的硬体和软体的进步。所需的技术。
2023 年 9 月，MVision AI 推出了第一个全面的基于指南的分割 (GBS) 解决方案，用于有效的放射治疗轮廓绘製。 Guide 有助于临床团队准确评估人工智慧生成的结构，从而使他们能够提高轮廓绘製技能。验证可以对轮廓进行视觉和体积比较，方便诊所观察相似点和差异。 Guide verify 和 Contour+ 的组合实施涵盖了放射治疗轮廓的所有临床需求。

因此，放射肿瘤学市场的市场参与者纷纷采取策略性倡议，预计将扩大市场成长并为放射肿瘤学市场创造充足的机会。

亚太地区放射肿瘤学市场概况

由于技术的重大进步，放射肿瘤学领域在中国发展迅速。合资企业在提高放射肿瘤系统的可及性方面发挥了至关重要的作用。透过这些倡议，公司也专注于开发高科技治疗产品。中国同辐射公司（CIRC）与美国放射治疗系统开发商Accuray于2019年1月成立了合资公司。这些措施显示了中国致力于发展国内放射肿瘤学技术，这将为未来几年的放射肿瘤学市场带来值得关注的前景。

亚太地区放射肿瘤学市场收入及 2031 年预测（百万美元）

亚太地区放射肿瘤学市场细分

亚太地区放射肿瘤学市场按类型、应用和国家分类。

根据类型，亚太地区放射肿瘤学市场分为外照射放射治疗和内照射放射治疗。 2023 年，体外放射治疗领域将占据更大的市场份额。

从应用来看，亚太地区放射肿瘤市场分为乳癌、摄护腺癌、肺癌、头颈癌、子宫颈癌等。 2023 年，乳癌细分市场占据最大的市场份额。

依国家/地区划分，亚太地区放射肿瘤学市场分为中国、日本、印度、澳洲、韩国和亚太地区其他地区。 2023年，中国在亚太地区放射肿瘤市场份额中占据主导地位。

Varian Medical Systems Inc、Elekta AB、Accuray Incorporated、IBA Worldwide (Ion Beam Applications SA)、Becton Dickinson and Co、Mevion Medical Systems、NTP RADIOISOTOPES、Mallinckrodt Plc、Panacea Medical Technologies Pvt. Ltd、和 Curium 是亚太地区放射肿瘤学市场上的一些领先公司。

Radiation Oncology holds tremendous potential in cancer treatment. Additionally, constant evolution in radiotherapy by the market players in terms of product development, innovation, product launch, product approval, merger, acquisition and partnerships, and others is expected to contribute the market growth. Some of the recent strategic initiatives taken place in the market are

In May 2024, Elekta launched its latest linear accelerator (linac), Evo, a CT-Linac with new high-definition AI enhanced imaging, capable of delivering offline and online adaptive radiation therapy as well as improved standard image-guided radiation therapy treatments.
In May 2024, The Icon Group collaborated with Cyberknife Australia Pty Ltd to establish up to 6 new radiation oncology clinics (proposed joint venture), which will provide radiation oncology treatments using the 'Cyberknife' system.
In May 2024, GE HealthCare launched Revolution RT, a new radiation therapy computed tomography (CT) solution with innovative hardware and software solutions to help increase imaging accuracy, while simplifying simulation workflow for a more personalized and seamless oncology care pathway experience for clinicians and patients.
In April 2024, Accuray Incorporated showcased advancement in hardware and software designed to improve the cancer treatment experience, at ESTRO 2024. The latest generation CyberKnife and Radixact platforms provide medical care teams with the technology necessary for expanding the curative power of radiation therapy and delivering on the focus of this year's congress, bridging the care gap.
In September 2023, MVision AI launched the first comprehensive Guideline-Based Segmentation (GBS) solution for effective radiation therapy contouring. Guide facilitates clinical teams to accurately evaluate AI-generated structures, thus enabling them to refine their contouring skills. Verify allows visual and volumetric comparison of contours, facilitating clinics to observe similarities and differences. The combined implementation of Guide Verify and Contour+ encompasses all clinical needs in radiotherapy contouring.

Therefore, surging strategic initiatives among market players operating in radiation oncology market which are expected to amplify the market growth and create ample opportunities for the radiation oncology market.

Asia Pacific Radiation Oncology Market Overview

The field of radiation oncology has been developing quickly in China due to significant technological advancements. Joint ventures have played a crucial role in increasing the accessibility of radiation oncology systems. With these initiatives, companies also focus on developing high-tech therapy products. China Isotope and Radiation Corporation (CIRC) and Accuray, a US-based developer of radiotherapy systems, established a joint venture in January 2019. This project uses Accuray's cutting-edge treatment solutions and local manufacturing capabilities to address the unmet needs in the Chinese market. Such initiatives demonstrate China's dedication to developing radiation oncology skills within the country, which would generate noteworthy prospects for the radiation oncology market in the coming years.

Asia Pacific Radiation Oncology Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Radiation Oncology Market Segmentation

The Asia Pacific radiation oncology market is categorized into types, application, and country.

Based on types, the Asia Pacific radiation oncology market is bifurcated into external beam radiation therapy and internal beam radiation therapy. The external beam radiation therapy segment held a larger market share in 2023.

In terms of application, the Asia Pacific radiation oncology market is categorized into breast cancer, prostate cancer, lung cancer, head and neck cancer, cervical cancer, and others. The breast cancer segment held the largest market share in 2023.

By country, the Asia Pacific radiation oncology market is segmented into the China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific radiation oncology market share in 2023.

Varian Medical Systems Inc, Elekta AB, Accuray Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson and Co, Mevion Medical Systems, NTP RADIOISOTOPES, Mallinckrodt Plc, Panacea Medical Technologies Pvt. Ltd,, and Curium are some of the leading companies operating in the Asia Pacific radiation oncology market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Asia Pacific Radiation Oncology Market - Key Market Dynamics

4.1 Market Drivers:
- 4.1.1 Increasing Prevalence of Cancer
- 4.1.2 Initiatives to Support Developments in Radiation Oncology
4.2 Market Restraints
- 4.2.1 High Cost of Radiotherapy Equipment
4.3 Market Opportunities
- 4.3.1 Strategic Initiatives in Radiation Oncology
4.4 Future Trends
- 4.4.1 Technological Advancement in Radiation Oncology
4.5 Impact of Drivers and Restraints:

5. Radiation Oncology Market - Asia Pacific Market Analysis

5.1 Radiation Oncology Market Revenue (US$ Million), 2021-2031

6. Asia Pacific Radiation Oncology Market Analysis - by Types

6.1 External Beam Radiation Therapy
- 6.1.1 Overview
- 6.1.2 External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
6.2 Internal Beam Radiation Therapy
- 6.2.1 Overview
- 6.2.2 Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)

7. Asia Pacific Radiation Oncology Market Analysis - by Application

7.1 Breast Cancer
- 7.1.1 Overview
- 7.1.2 Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Prostate Cancer
- 7.2.1 Overview
- 7.2.2 Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Lung Cancer
- 7.3.1 Overview
- 7.3.2 Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Head and Neck Cancer
- 7.4.1 Overview
- 7.4.2 Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Cervical Cancer
- 7.5.1 Overview
- 7.5.2 Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Radiation Oncology Market - Country Analysis

8.1 Asia Pacific
- 8.1.1 Asia Pacific: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
  - 8.1.1.1 China: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 8.1.1.1.1 China: Radiation Oncology Market Breakdown, by Types
    - 8.1.1.1.2 China: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 8.1.1.1.3 China: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 8.1.1.1.4 China: Radiation Oncology Market Breakdown, by Application
  - 8.1.1.2 Japan: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 8.1.1.2.1 Japan: Radiation Oncology Market Breakdown, by Types
    - 8.1.1.2.2 Japan: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 8.1.1.2.3 Japan: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 8.1.1.2.4 Japan: Radiation Oncology Market Breakdown, by Application
  - 8.1.1.3 India: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 8.1.1.3.1 India: Radiation Oncology Market Breakdown, by Types
    - 8.1.1.3.2 India: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 8.1.1.3.3 India: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 8.1.1.3.4 India: Radiation Oncology Market Breakdown, by Application
  - 8.1.1.4 Australia: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 8.1.1.4.1 Australia: Radiation Oncology Market Breakdown, by Types
    - 8.1.1.4.2 Australia: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 8.1.1.4.3 Australia: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 8.1.1.4.4 Australia: Radiation Oncology Market Breakdown, by Application
  - 8.1.1.5 South Korea: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 8.1.1.5.1 South Korea: Radiation Oncology Market Breakdown, by Types
    - 8.1.1.5.2 South Korea: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 8.1.1.5.3 South Korea: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 8.1.1.5.4 South Korea: Radiation Oncology Market Breakdown, by Application
  - 8.1.1.6 Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 8.1.1.6.1 Rest of APAC: Radiation Oncology Market Breakdown, by Types
    - 8.1.1.6.2 Rest of APAC: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 8.1.1.6.3 Rest of APAC: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 8.1.1.6.4 Rest of APAC: Radiation Oncology Market Breakdown, by Application

9. Radiation Oncology Market - Industry Landscape

9.1 Overview
9.2 Growth Strategies in Radiation Oncology Market
9.3 Organic Growth Strategies
- 9.3.1 Overview
9.4 Inorganic Growth Strategies
- 9.4.1 Overview

10. Company Profiles

10.1 Varian Medical Systems Inc
- 10.1.1 Key Facts
- 10.1.2 Business Description
- 10.1.3 Products and Services
- 10.1.4 Financial Overview (Siemens Healthineers AG)
- 10.1.5 SWOT Analysis
- 10.1.6 Key Developments
10.2 Elekta AB
- 10.2.1 Key Facts
- 10.2.2 Business Description
- 10.2.3 Products and Services
- 10.2.4 Financial Overview
- 10.2.5 SWOT Analysis
- 10.2.6 Key Developments
10.3 Accuray Incorporated
- 10.3.1 Key Facts
- 10.3.2 Business Description
- 10.3.3 Products and Services
- 10.3.4 Financial Overview
- 10.3.5 SWOT Analysis
- 10.3.6 Key Developments
10.4 IBA Worldwide (Ion Beam Applications SA)
- 10.4.1 Key Facts
- 10.4.2 Business Description
- 10.4.3 Products and Services
- 10.4.4 Financial Overview
- 10.4.5 SWOT Analysis
- 10.4.6 Key Developments
10.5 Becton Dickinson and Co
- 10.5.1 Key Facts
- 10.5.2 Business Description
- 10.5.3 Products and Services
- 10.5.4 Financial Overview
- 10.5.5 SWOT Analysis
- 10.5.6 Key Developments
10.6 Mevion Medical Systems
- 10.6.1 Key Facts
- 10.6.2 Business Description
- 10.6.3 Products and Services
- 10.6.4 Financial Overview
- 10.6.5 SWOT Analysis
- 10.6.6 Key Developments
10.7 NTP RADIOISOTOPES
- 10.7.1 Key Facts
- 10.7.2 Business Description
- 10.7.3 Products and Services
- 10.7.4 Financial Overview
- 10.7.5 SWOT Analysis
- 10.7.6 Key Developments
10.8 Mallinckrodt Plc
- 10.8.1 Key Facts
- 10.8.2 Business Description
- 10.8.3 Products and Services
- 10.8.4 Financial Overview
- 10.8.5 SWOT Analysis
- 10.8.6 Key Developments
10.9 Panacea Medical Technologies Pvt. Ltd
- 10.9.1 Key Facts
- 10.9.2 Business Description
- 10.9.3 Products and Services
- 10.9.4 Financial Overview
- 10.9.5 SWOT Analysis
- 10.9.6 Key Developments
10.10 Curium
- 10.10.1 Key Facts
- 10.10.2 Business Description
- 10.10.3 Products and Services
- 10.10.4 Financial Overview
- 10.10.5 SWOT Analysis
- 10.10.6 Key Developments

11. Appendix

11.1 About The Insight Partners
11.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Asia Pacific Radiation Oncology Market Segmentation
Table 2. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 3. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 4. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 5. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 6. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 7. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 8. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 9. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 10. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 11. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 12. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 13. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 14. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 15. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 16. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 17. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 18. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 19. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 20. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 21. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 22. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 23. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 24. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 25. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 26. Recent Organic Growth Strategies in Radiation Oncology Market
Table 27. Recent Inorganic Growth Strategies in the Radiation Oncology Market
Table 28. Glossary of Terms, Radiation Oncology Market

List Of Figures

Figure 1. Asia Pacific Radiation Oncology Market Segmentation, by Country
Figure 2. Radiation Oncology Market - Key Market Dynamics
Figure 3. Statistics at Glance, Global, 2022
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Radiation Oncology Market Revenue (US$ Million), 2021-2031
Figure 6. Radiation Oncology Market Share (%) - by Types (2023 and 2031)
Figure 7. External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Radiation Oncology Market Share (%) - by Application (2023 and 2031)
Figure 10. Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Asia Pacific Radiation Oncology Market, by Key Countries - Revenue (2023) (US$ Million)
Figure 17. Asia Pacific: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 18. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 19. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 20. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 21. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 22. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 23. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 24. Growth Strategies in Radiation Oncology Market